Loading icon
Three MS Studies on Smoking, Cholesterol and Risk Variants
Three MS Studies on Smoking, Cholesterol and Risk Variants

Three MS studies take a factor established for the disease and test how far it reaches. Hedström and colleagues follow 6,807 Swedish patients, where smoking raises the hazard of disability worsening mainly in those lacking HLA-A*02:01. Williams and colleagues return to the MS-STAT2 trial, where a cholesterol ratio measured once tracks disability at the start and later lesion growth, and simvastatin removes the lesion relationship. Buyukkurt and colleagues find no causal effect of MS liability on twelve cancers, yet nine loci are shared between them, most of these with opposite directions of effect.

Read more